CYC-3

N/A

Report date: 2025/01/26 18:15:40
NME

Base Information

Drug NameCYC-3
Drug Alias Nameaurora kinase A inhibitor (Cyclacel)CYC-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitors
TargetsSerine/threonine-protein kinase Aurora-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyclacel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyclacel Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A